MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$247,221K
Cash and cash
equivalents
$129,883K
Collaboration receivable
$7,000K
Other receivables
$4,600K
Prepaid expenses and
other current assets
$4,481K
Total property and
equipment, at cost
$53,599K
Total current assets
$393,185K
Property and equipment,
net
$25,986K
Operating lease
right-of-use assets
$24,386K
Restricted cash
$4,954K
Other long-term
assets
$148K
Less accumulated
depreciation
$27,613K
Total assets
$448,659K
Total liabilities and
stockholders' equity
$448,659K
Total stockholders'
equity
$233,056K
Total liabilities
$215,603K
Accumulated deficit
-$477,214K
Accumulated other
comprehensive loss
-$3,827K
Additional paid-in capital
$714,090K
Deferred revenue, net of
current
$111,332K
Total current
liabilities
$64,212K
Operating lease
liability, net of current
$34,794K
Defined benefit plan
liability
$5,265K
Common stock, 0.0001
par value...
$7K
Current deferred
revenue
$29,571K
Accrued expenses and
other current...
$26,694K
Current portion of
operating lease liability
$4,397K
Accounts payable
$3,550K
Back
Back
Balance Sheet
source: myfinsight.com
Monte Rosa Therapeutics, Inc. (GLUE)
Monte Rosa Therapeutics, Inc. (GLUE)